Cargando…
A single exercise bout enhances the manufacture of viral-specific T-cells from healthy donors: implications for allogeneic adoptive transfer immunotherapy
Cytomegalovirus (CMV) and Epstein-Barr virus (EBV) infections remain a major cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). The adoptive transfer of donor-derived viral-specific cytotoxic T-cells (VSTs) is an effective treatment for controlling CMV...
Autores principales: | Spielmann, Guillaume, Bollard, Catherine M., Kunz, Hawley, Hanley, Patrick J., Simpson, Richard J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867645/ https://www.ncbi.nlm.nih.gov/pubmed/27181409 http://dx.doi.org/10.1038/srep25852 |
Ejemplares similares
-
Specific Adoptive T-Cell Therapy for Viral and Fungal Infections
por: Lum, Lawrence G., et al.
Publicado: (2018) -
Industrializing Autologous Adoptive Immunotherapies: Manufacturing Advances and Challenges
por: Iyer, Rohin K., et al.
Publicado: (2018) -
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy
por: Lupo, Kyle B., et al.
Publicado: (2019) -
Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation
por: Kaeuferle, Theresa, et al.
Publicado: (2019) -
The time is now: moving toward virus-specific T cells after allogeneic hematopoietic stem cell transplantation as the standard of care
por: Saglio, Francesco, et al.
Publicado: (2014)